The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancer.
Hayne D, Ong K, Swarbrick N, McCombie SP, Moe A, Hawks C, Viswambaram P, Conduit C, Liow E, Spalding L, Lim J, Ferguson T, Meehan K, Davis ID, Redfern AD.
Hayne D, et al. Among authors: swarbrick n.
BJU Int. 2024 Mar 12. doi: 10.1111/bju.16325. Online ahead of print.
BJU Int. 2024.
PMID: 38469652